Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors

A significant unmet need for patients with multiple sclerosis (MS) is the lack of U.S. Food and Drug Administration (FDA)-approved remyelinating therapies. We have identified a compelling remyelinating agent, bazedoxifene (BZA), a European Medicines Agency (EMA)-approved (and FDA-approved in combina...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurosci
Main Authors: Rankin, Kelsey A., Mei, Feng, Kim, Kicheol, Shen, Yun-An A., Mayoral, Sonia R., Desponts, Caroline, Lorrain, Daniel S., Green, Ari J., Baranzini, Sergio E., Chan, Jonah R., Bove, Riley
Formato: Artigo
Idioma:Inglês
Publicado: Society for Neuroscience 2019
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6433770/
https://ncbi.nlm.nih.gov/pubmed/30696729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1530-18.2019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares